title: Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator.
abstract: OBJECTIVE
  Recent studies suggest that allelic loss of sequences from the long arm of chromosome 18 may be a useful prognostic indicator in colorectal cancer. The aim of the present study was to confirm whether 18q loss of heterozygosity (LOH) is of prognostic value in patients with colon cancer.
  
  
  METHODS
  Genomic DNA was prepared from archival tumor and corresponding normal tissue specimens from 151 patients who had undergone potentially curative surgery for adenocarcinoma of the colon. Polymerase chain reaction (PCR) was used to assess allelic loss of five chromosome 18q microsatellite markers in the tumors. The relationship between allelic loss and disease-free and disease-specific survival was investigated.
  
  
  RESULTS
  LOH was detected in 67 of 126 tumors. Chromosome 18q allelic loss was a negative prognostic indicator of both disease-free (relative risk [RR], 1.65; P = .01) and disease-specific survival (RR, 2.0; P = .003). 18q loss was also associated with significantly reduced disease-free and disease-specific survival in patients with stage II (P = .05 and P = .0156) and III (P = .038 and P = .032) disease.
  
  
  CONCLUSIONS
  Chromosome 18q allelic loss is a prognostic marker in colorectal cancers. Chromosome 18 LOH studies may be useful in identifying patients with stage II disease who are at high risk for recurrence, and as such might benefit from adjuvant chemotherapy.
authors.affiliation: Department of Surgery, Washington University School of Medicine, St Louis, MO 63110, USA.
authors.forename: O A
authors.initials: OA
authors.lastname: Ogunbiyi
authors.forename: P J
authors.initials: PJ
authors.lastname: Goodfellow
authors.forename: K
authors.initials: K
authors.lastname: Herfarth
authors.forename: G
authors.initials: G
authors.lastname: Gagliardi
authors.forename: P E
authors.initials: PE
authors.lastname: Swanson
authors.forename: E H
authors.initials: EH
authors.lastname: Birnbaum
authors.forename: T E
authors.initials: TE
authors.lastname: Read
authors.forename: J W
authors.initials: JW
authors.lastname: Fleshman
authors.forename: I J
authors.initials: IJ
authors.lastname: Kodner
authors.forename: J F
authors.initials: JF
authors.lastname: Moley
mesh_terms: D000230:Adenocarcinoma / Q000235:genetics* / Q000401:mortality / Q000473:pathology; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002887:Chromosomes, Human, Pair 18 / Q000235:genetics*; D003110:Colonic Neoplasms / Q000235:genetics* / Q000401:mortality / Q000473:pathology; D018572:Disease-Free Survival; D005260:Female; D005819:Genetic Markers; D006801:Humans; D015993:Life Tables; D019656:Loss of Heterozygosity; D008297:Male; D018895:Microsatellite Repeats / Q000235:genetics; D008875:Middle Aged; D016133:Polymerase Chain Reaction; D011379:Prognosis; D015996:Survival Rate
chemical_list: D005819:Genetic Markers